SIX:BION

BB Biotech AG · SIX · Financial Services · CHF · FY for 2025

Figures on this page computed 2026-11-07 15:38 UTC

Last close

n/aCHF

Market data

We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.

4.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
n/mNet marginnet income exceeds revenue
Net income exceeds revenue.
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
402.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
3.5%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed

Growth is the furthest below its sector's middle: 0.40 against 0.56 on the market's range.

Five bars, one line

lens 7 of 9

0.14x

1.11x

0.66x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

3 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales0.14x
Its own average over 10 years, 534.0M.
Profit1.11x
Its own average over 10 years, 520.1M.
Free cash flow0.66x
Its own average over 10 years, 469.4M.
Debtn/a
Its own average over 9 years, 152.6M.
Pricen/a
Its own average over 0 years. Market data

Sales is furthest from its own average, at 0.14 times.

The filed years, as a table

Each line is 100 at 2013-12-31, the first year we hold.

Filed year	Sales	Profit	Shares in issue
2013-12-31	100.0	100.0	100.0
2014-12-31	157.4	157.8	99.4
2015-12-31	70.3	70.1	98.0
2017-12-31	73.9	73.8	97.1
2019-12-31	73.1	72.7	97.2
2020-12-31	74.6	74.2	97.2
2022-12-31	0.0	-38.4	97.2
2023-12-31	0.0	-22.2	96.3
2024-12-31	11.9	8.1	96.2
2025-12-31	8.2	62.0	96.3

How sales was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: CHF

How profit was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: CHF

How shares in issue was got

Source: computed
Statement: income
Fiscal year: 2025
Reported in: CHF

Figures behind the shape

Growth

-35.7%

faster is higher, placed against 4,950 companies as of 2026-11-06

Five-year revenue growth rate-35.7%
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed
Five-year EPS growth rate-3.3%
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed
One-year change in net income661.7%
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed

Returns on capital

20.8%

higher is higher, placed against 5,089 companies as of 2026-11-06

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity20.8%
Net Income / Shareholders' Equity x 100
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets20.8%
Net Income / Total Assets x 100
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025

Margins

99.9%

wider is higher, placed against 3,412 companies as of 2026-11-06

Gross margin99.9%
Gross Profit / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin764.0%
Operating Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Net marginn/mnet income exceeds revenue
Net income exceeds revenue.
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin402.5%
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025

Price

4.9x

cheaper is higher, placed against 4,362 companies as of 2026-11-06

Price to earnings4.9x
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed
- Computed from the filing for 2025
Price to book1.0x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio36.8x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025

Safety

1324.7x

safer is higher, placed against 1,436 companies as of 2026-11-06

Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ration/a
We do not hold this figure for this company, so there is nothing to place.
Current Assets / Current Liabilities
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage1324.7x
Operating Income / Interest Expense
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Scoren/a
This measure is not defined for this kind of company, so there is no peer group it belongs in.
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025

What it pays out

3.5%

more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06

Dividend yield3.5%
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed
Payout ratio17.0%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Taken on
2026-11-07
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio3.1x
Source
computed
Taken on
2026-11-07
Reported in
CHF
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.